Webcast CME

How to Obtain AMA PRA Category 1 Credit

  1. Complete the Activity.
  2. Complete the CME posttest (each question must be answered correctly).
  3. Log into your myCME account.
  4. Complete the credit and evaluation form.
  5. Print your personalized CME certificate.
  6. Credit can only be claimed once for this activity.

Multiple Sclerosis Monthly Reports

Switching MS Medicines:
What Do We Know? What Do We Do?

Print this Content

Release Date: November 13, 2015
Renewal Date: November 13, 2016
Expiration Date: November 13, 2017

Estimated Time of Completion: 30 minutes

Description

Multiple Sclerosis Monthly Reports is a case-based CME-certified webcast series designed to provide health care providers with the most current information about the identification, management, and treatment of patients with MS, with the goal of improving clinical outcomes and enhancing patient quality of life. The overall goal of this series is to enhance participants' knowledge, competence, and skills in the best clinical practices in the care of patients with MS.

The Switching MS Medicines: What Do We Know? What Do We Do? webcast highlights why one would switch MS medicines and the disease activity parameters that support the switching of MS disease-modifying therapies.

Learning Objectives

  1. Describe the different reasons that can lead to switching MS medicines.
  2. Review MS breakthrough disease activity parameters that should be followed in daily practice.
  3. Highlight the results of recent switch studies involving approved MS disease-modifying therapies.

Target Audience

This activity is designed for neurologists, internal medicine physicians, and other health care professionals who manage patients with multiple sclerosis.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director and Moderator

Alexander D. Rae-Grant, MD
Clinical Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Director of Resident and Student Education
Mellen Center for Multiple Sclerosis Treatment and Research
Cleveland Clinic
Cleveland, OH

Faculty

Patricia K. Coyle, MD
Professor and Vice Chair (Clinical Affairs)
Director, MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, NY

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that she may have a relationship which, in the context of her presentation, could be perceived as a potential conflict of interest:

Patricia K. Coyle, MD
  Abbvie Pharmaceuticals Consulting
  Accordant; Acorda Therapeutics; Bayer Healthcare; Genentech/Roche; Genzyme/Sanofi; Merck Serono; Teva Membership on advisory committee or review panels
  Actelion; Opexa Multicenter research trials
  Novartis Pharmaceuticals Membership on advisory committee or review panels; Multicenter research trials
  Biogen Idec Membership on advisory committee or review panels; Research Support

The following faculty has indicated he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Alexander Rae-Grant, MD

The Cleveland Clinic Foundation Center for Continuing Education acknowledges
educational grants for partial support of this activity from
:
Biogen Idec
EMD Serono
Genentech, USA

This CME activity was produced by Cleveland Clinic Foundation Center for Continuing Education and
Cleveland Clinic Mellen Center for Multiple Sclerosis.